Novo Nordisk Sees First-Half U.S. Launch of Tresiba

Jan. 31 (Bloomberg) -- Jesper Brandgaard, chief financial officer of Novo Nordisk A/S, discusses the company's fourth-quarter profit reported today, growth expectations for the insulin market and the outlook for U.S. approval of its Tresiba diabetes treatment. He speaks from Copenhagen with Francine Lacqua on Bloomberg Television's "The Pulse." (Source: Bloomberg)
Does Apple TV Need a Revamp?
25:40 - Homebrew VC Partner Hunter Walk, Technalysis Founder Bob O’Donnell and IDC Chief Research Officer Crawford Del Prete discuss Apple to unveil a new TV box this fall and the future of Apple’s streaming service. They speak with Bloomberg’s Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Why Would Microsoft Invest in Uber?
  • Why U.S. Wage Growth Has Screeched to a Halt
  • The China Slowdown Felt Around the World